University of California, San Francisco
The University of California, San Francisco (UCSF) is a prominent educational institution established in 1897, specializing in health sciences. It offers a range of programs across various fields, including biological, biomedical, pharmaceutical, nursing, social and behavioral sciences, dentistry, and medicine. UCSF comprises several schools, including the School of Medicine, School of Dentistry, School of Nursing, School of Pharmacy, and Continuing Medical Education. The university is known for its significant contributions to research and development, particularly in areas such as advanced cytometry, automated digital pathology, and single-cell genomics. With an endowment of $873 million, UCSF supports a robust academic and research environment, fostering innovation and the advancement of medical technologies. The institution has successfully secured over $40 million in extramural funding for its research initiatives, further enhancing its capabilities and impact in the biomedical field.
Top Regions
Top Stages
2 past transactions
ArsenalBio
Series B in 2022
ArsenalBio is a programmable cell therapy company established in 2019, focused on developing and commercializing innovative immune cell therapies, particularly for cancer treatment. The company utilizes advanced technologies, including CRISPR-based genome engineering, synthetic biology, and machine learning, to create multifunctional T-cell therapies. ArsenalBio's approach involves the precise insertion of large synthetic DNA sequences, enabling the generation of next-generation autologous T-cell therapies. By integrating these cutting-edge methods, ArsenalBio aims to enhance the effectiveness and safety of immune cell therapies, reduce costs for healthcare providers, and improve market access, ultimately broadening patient outcomes and making these therapies more widely available.
Hazel Health
Series C in 2020
Hazel Health, Inc. is a healthcare company focused on enhancing student health and well-being by providing accessible healthcare services. Founded in 2015 and headquartered in San Francisco, California, the company offers a telehealth platform that allows K-12 students to connect with healthcare professionals through live video consultations, whether they are in school or at home. This innovative application enables students to receive timely medical attention for a variety of conditions, with the capability for doctors to prescribe over-the-counter medications at school, pending parental approval. By partnering with schools and their nursing staff, Hazel Health aims to ensure that every child has access to necessary pediatric care, thereby supporting their health and readiness to learn. The company was previously known as HippoMD, Inc. before rebranding in September 2017.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.